Anti-EphA2 receptor (1C1)-vcMMAE ADC (CAT#: ADC-113LCT)

This ADC product is composed of an anti-EphA2 receptor antibody (clone 1C1) conjuagated via a Mc linker to MMAF (1C1-vcMMAE). It has demonstrated a response in treatment by a MOA (Mechanism of Action) of Depolymerize Microtubules.


Specific Inquiry
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
RNA Expression

Specifications

  • Antibody Overview
  • Fully Human monoclonal Antibody (1C1) Anti-EphA2 receptor
  • Clone
  • 1C1
  • Linker
  • Mc (maleimidocaproyl)
  • Linker Class/Description
  • Noncleavable linker is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.
  • Drug
  • MMAF (Monomethyl auristatin F)
  • Drug Class/Description
  • Auristatins are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.

Target

  • Introduction
  • This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Mutations in this gene are the cause of certain genetically-related cataract disorders.[provided by RefSeq, May 2010]
  • Alternative Names
  • EPHA2; EPH receptor A2; ECK; CTPA; ARCC2; CTPP1; CTRCT6; ephrin type-A receptor 2; soluble EPHA2 variant 1; tyrosine-protein kinase receptor ECK; epithelial cell receptor protein tyrosine kinase;

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 1C1"

See other products for "EPHA2"

Recombinant Antibody

CAT Product Name Application Type
MOB-1460z Mouse Anti-EPHA2 Recombinant Antibody (clone 31G12) WB, ELISA, ICC, IF Mouse IgG2b, κ
HPAB-0450-CN Mouse Anti-EPHA2 Recombinant Antibody (HPAB-0450-CN) ELISA, WB, FC, IP Mouse IgG2a
HPAB-0452-CN Human Anti-EPHA2 Recombinant Antibody (HPAB-0452-CN) ELISA, WB, FC, IP Humanized IgG1
HPAB-0453-CN Human Anti-EPHA2 Recombinant Antibody (clone 4H5) ELISA, FC, IF Humanized IgG
HPAB-0454-CN Human Anti-EPHA2 Recombinant Antibody (clone 2A4) ELISA, FC, IF, Agonist Humanized IgG

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-1164 Hi-Affi™ Rabbit Anti-EPHA2 Recombinant Antibody (clone DS1164AB) WB Rabbit IgG

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for ADC-113LCT. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare